Upgrade to SI Premium - Free Trial

Veeco Reports Fourth Quarter and Fiscal Year 2016 Financial Results

February 16, 2017 4:05 PM

PLAINVIEW, NY -- (Marketwired) -- 02/16/17 --

Veeco Instruments Inc. (NASDAQ: VECO)

Fourth Quarter 2016 Highlights

Full Year 2016 Highlights

Veeco Instruments Inc. (NASDAQ: VECO) announced financial results for its fourth quarter and fiscal year ended December 31, 2016. Results are reported in accordance with U.S. generally accepted accounting principles ("GAAP") and are also reported adjusting for certain items ("Non-GAAP"). A reconciliation between GAAP and Non-GAAP operating results is provided at the end of this press release.

                                                                            
----------------------------------------------------------------------------
 U.S. Dollars in millions, except per share data                            
----------------------------------------------------------------------------
                                       4th Quarter            Full Year     
                                --------------------------------------------
GAAP Results                       Q4 '16     Q4 '15      2016       2015   
----------------------------------------------------------------------------
Revenue                             $93.6     $106.5     $332.5     $477.0  
----------------------------------------------------------------------------
Net income (loss)                  ($5.0)     ($9.8)    ($122.2)    ($32.0) 
----------------------------------------------------------------------------
Diluted earnings (loss) per                                                 
 share                             ($0.13)    ($0.25)    ($3.11)    ($0.80) 
----------------------------------------------------------------------------
                                                                            
                                       4th Quarter            Full Year     
                                --------------------------------------------
Non-GAAP Results                   Q4 '16     Q4 '15      2016       2015   
----------------------------------------------------------------------------
Net income (loss)                   $3.8       $0.6      ($11.3)     $22.1  
----------------------------------------------------------------------------
Adjusted EBITDA                     $6.2       $4.4       $4.2       $41.7  
----------------------------------------------------------------------------
Diluted earnings (loss) per                                                 
 share                              $0.09      $0.01     ($0.29)     $0.54  
----------------------------------------------------------------------------
                                                                            

"Veeco's fourth quarter financial results marked a strong finish to a challenging year. Revenues increased by 9% and adjusted EBITDA more than doubled sequentially over the prior quarter. We improved gross margins for the third consecutive year, delivering on our objective to achieve gross margins of 40% or better. Our performance demonstrates solid operational execution and underscores our focus on improving through-cycle profitability," commented John R. Peeler, Chairman and Chief Executive Officer.

"Entering 2017, we are seeing healthy LED industry dynamics and positive business momentum. We closed an exclusive, multi-year agreement with OSRAM Opto Semiconductors GmbH to supply Metal Organic Chemical Vapor Deposition ("MOCVD") and Precision Surface Processing ("PSP") systems for their new high volume LED production facility in Kulim. We made significant progress in growing our Advanced Packaging business, increasing sales into the Advanced Packaging, MEMS & RF markets by ~10% year over year. In addition, our recently announced agreement to acquire Ultratech will establish Veeco as a leading equipment supplier to the Advanced Packaging industry. We are excited by this proposed combination, which is expected to increase our scale, diversify our revenue and provide a stable platform to drive long-term shareholder value. The transaction is subject to regulatory clearance and approval by Ultratech's stockholders and is expected to close in the second quarter," Mr. Peeler concluded.

Guidance and Outlook

The following guidance is provided for Veeco's first quarter 2017:

Please refer to the tables at the end of this press release for further details.

Conference Call Information

A conference call reviewing these results has been scheduled for today, February 16, 2017 starting at 5:00pm ET. To join the call, dial 877-741-4245 (toll free) or 719-325-4942 and use passcode 2499397. The call will also be webcast live on the Veeco website at ir.veeco.com. A replay of the webcast will be made available on the Veeco website beginning at 8:00pm ET this evening. We will post an accompanying slide presentation to our website prior to the beginning of the call.

About Veeco

Veeco's process equipment solutions enable the manufacture of LEDs, displays, power electronics, compound semiconductors, hard disk drives, semiconductors, MEMS and wireless chips. We are the leader in MOCVD, MBE, Ion Beam, Wet Etch single wafer processing and other advanced thin film process technologies. Our high performance systems drive innovation in energy efficiency, consumer electronics and network storage and allow our customers to maximize productivity and achieve lower cost of ownership. For information on our company, products and worldwide service and support, please visit www.veeco.com.

Additional Information and Where to Find It
In connection with the proposed acquisition of Ultratech ("Ultratech") by Veeco ("Veeco") pursuant to the terms of an Agreement and Plan of Merger by and among Ultratech, Veeco and Merger Sub, Veeco will file with the Securities and Exchange Commission (the "SEC") a Registration Statement on Form S-4 (the "Form S-4") that will contain a proxy statement of Ultratech and a prospectus of Veeco, which proxy statement/prospectus will be mailed or otherwise disseminated to Ultratech's stockholders when it becomes available. Investors are urged to read the proxy statement/prospectus (including all amendments and supplements) because they will contain important information. Investors may obtain free copies of the proxy statement/prospectus when it becomes available, as well as other filings containing information about Veeco and Ultratech, without charge, at the SEC's Internet site (http://www.sec.gov). Copies of these documents may also be obtained for free from the companies' web sites at www.Veeco.com or www.Ultratech.com.

Participants in Solicitation
Veeco, Ultratech and their respective officers and directors may be deemed to be participants in the solicitation of proxies from the stockholders of Ultratech in connection with the proposed transaction. Information about Veeco's executive officers and directors is set forth in its Annual Report on Form 10-K, which was filed with the SEC on February 25, 2016 and its proxy statement for its 2016 annual meeting of stockholders, which was filed with the SEC on March 22, 2016. Information about Ultratech's executive officers and directors is set forth in its Annual Report on Form 10-K, which was filed with the SEC on February 26, 2016, Amendment No. 1 to its Annual Report on Form 10-K, which was filed with the SEC on April 22, 2016, and the proxy statements for its 2016 annual meeting of stockholders, which were filed with the SEC on June 10, 2016 and June 13, 2016. Investors may obtain more detailed information regarding the direct and indirect interests of the Veeco, Ultratech and their respective executive officers and directors in the acquisition by reading the preliminary and definitive proxy statement/prospectus regarding the transaction, which will be filed with the SEC.

Forward-Looking Statements
This written communication also contains forward-looking statements that involve risks and uncertainties concerning Veeco's proposed acquisition of Ultratech, Ultratech's and Veeco's expected financial performance, as well as Ultratech's and Veeco's strategic and operational plans. Actual events or results may differ materially from those described in this written communication due to a number of risks and uncertainties. The potential risks and uncertainties include, among others, the possibility that Ultratech may be unable to obtain required stockholder approval or that other conditions to closing the transaction may not be satisfied, such that the transaction will not close or that the closing may be delayed; the reaction of customers to the transaction; general economic conditions; the transaction may involve unexpected costs, liabilities or delays; risks that the transaction disrupts current plans and operations of the parties to the transaction; the ability to recognize the benefits of the transaction; the amount of the costs, fees, expenses and charges related to the transaction and the actual terms of any financings that will be obtained for the transaction; the outcome of any legal proceedings related to the transaction; the occurrence of any event, change or other circumstances that could give rise to the termination of the transaction agreement. In addition, please refer to the documents that Veeco and Ultratech file with the SEC on Forms 10-K, 10-Q and 8-K. The filings by Veeco and Ultratech identify and address other important factors that could cause its financial and operational results to differ materially from those contained in the forward-looking statements set forth in this written communication.

All forward-looking statements speak only as of the date of this written communication nor, in the case of any document incorporated by reference, the date of that document. Neither Veeco nor Ultratech is under any duty to update any of the forward-looking statements after the date of this written communication to conform to actual results.

-financial tables attached-

                                                                            
                  Veeco Instruments Inc. and Subsidiaries                   
              Condensed Consolidated Statements of Operations               
                  (in thousands, except per share amounts)                  
                                                                            
                            Three months ended        For the year ended    
                               December 31,              December 31,       
                         ------------------------  ------------------------ 
                             2016         2015         2016         2015    
                         -----------  -----------  -----------  ----------- 
Net sales                $    93,609  $   106,543  $   332,451  $   477,038 
Cost of sales                 57,601       67,757      199,593      299,797 
                         -----------  -----------  -----------  ----------- 
Gross profit                  36,008       38,786      132,858      177,241 
                         -----------  -----------  -----------  ----------- 
Operating expenses, net:                                                    
  Research and                                                              
   development                17,471       20,639       81,016       78,543 
  Selling, general, and                                                     
   administrative             19,412       21,036       77,642       90,188 
  Amortization of                                                           
   intangible assets           3,434        5,802       19,219       27,634 
  Restructuring                1,646        1,170        5,640        4,679 
  Asset impairment              (142)           -       69,520          126 
  Other, net                    (660)          98          223         (697)
Total operating                                                             
 expenses, net                41,161       48,745      253,260      200,473 
Operating income (loss)       (5,153)      (9,959)    (120,402)     (23,232)
  Interest income, net           245          145          958          586 
Income (loss) before                                                        
 income taxes                 (4,908)      (9,814)    (119,444)     (22,646)
  Income tax expense              90          (26)       2,766        9,332 
Net income (loss)        $    (4,998) $    (9,788) $  (122,210) $   (31,978)
                         -----------  -----------  -----------  ----------- 
                                                                            
Income (loss) per common                                                    
 share:                                                                     
  Basic                  $     (0.13) $     (0.25) $     (3.11) $     (0.80)
  Diluted                $     (0.13) $     (0.25) $     (3.11) $     (0.80)
                                                                            
Weighted average number                                                     
 of shares:                                                                 
  Basic                       39,267       39,794       39,340       39,742 
  Diluted                     39,267       39,794       39,340       39,742 
                                                                            
                                                                            
                   Veeco Instruments Inc. and Subsidiaries                  
                    Condensed Consolidated Balance Sheets                   
                               (in thousands)                               
                                                                            
                                                  December 31,  December 31,
                                                      2016          2015    
                                                 ------------- -------------
Assets                                                                      
Current assets:                                                             
  Cash and cash equivalents                      $     277,444 $     269,232
  Short-term investments                                66,787       116,050
  Accounts receivable, net                              58,020        49,524
  Inventories                                           77,063        77,469
  Deferred cost of sales                                 6,160         2,100
  Prepaid expenses and other current assets             16,034        22,760
  Assets held for sale                                       -         5,000
    Total current assets                               501,508       542,135
Property, plant and equipment, net                      60,646        79,590
Intangible assets, net                                  58,378       131,674
Goodwill                                               114,908       114,908
Deferred income taxes                                    2,045         1,384
Other assets                                            21,047        21,098
                                                 ------------- -------------
    Total assets                                 $     758,532 $     890,789
                                                 ============= =============
                                                                            
Liabilities and stockholders' equity                                        
Current liabilities:                                                        
  Accounts payable                               $      22,607 $      30,074
  Accrued expenses and other current liabilities        33,201        49,393
  Customer deposits and deferred revenue                85,022        76,216
  Income taxes payable                                   2,311         6,208
  Current portion of long-term debt                        368           340
                                                 ------------- -------------
    Total current liabilities                          143,509       162,231
Deferred income taxes                                   13,199        11,211
Long-term debt                                             826         1,193
Other liabilities                                        6,403         1,539
                                                 ------------- -------------
    Total liabilities                                  163,937       176,174
                                                                            
    Total stockholders' equity                         594,595       714,615
                                                 ------------- -------------
                                                                            
      Total liabilities and stockholders' equity $     758,532 $     890,789
                                                 ------------- -------------
                                                                            
                                                                            
                  Veeco Instruments Inc. and Subsidiaries                   
             Reconciliation of GAAP to Non-GAAP Financial Data              
                  (in thousands, except per share amounts)                  
                                (unaudited)                                 
                                                                            
                                     Non-GAAP Adjustments                   
                              -----------------------------------           
Three months ended             Share-based                                  
December 31, 2016     GAAP    Compensation  Amortization  Other    Non-GAAP 
------------------ ---------- ------------- ------------ -------- ----------
Net sales          $  93,609                                      $  93,609 
Gross profit          36,008           316                   362     36,686 
Gross margin            38.5%                                          39.2%
Research and                                                                
 development          17,471          (292)                          17,179 
Selling, general,                                                           
 and                                                                        
 administrative                                                             
 and Other            18,752        (2,971)                  (44)    15,737 
Net income (loss)     (4,998)        3,579         3,434   1,740      3,755 
                                                                            
Income (loss) per                                                           
 common share:                                                              
  Basic            $   (0.13)                                     $    0.09 
  Diluted              (0.13)                                          0.09 
Weighted average                                                            
 number of shares:                                                          
  Basic               39,267                                         39,579 
  Diluted             39,267                                         39,990 
                                                                            
                  Veeco Instruments Inc. and Subsidiaries                   
                         Other Non-GAAP Adjustments                         
                               (in thousands)                               
                                (unaudited)                                 
                                                                            
Three months ended                                                          
December 31, 2016                                                           
------------------                                                          
  Asset impairment                                                     (142)
  Restructuring                                                       1,646 
  Acquisition                                                               
   related                                                               44 
  Accelerated                                                               
   depreciation                                                         362 
  ALD liquidation                                                      (429)
  Non-GAAP tax                                                              
   adjustment *                                                         259 
                                                                  ----------
  Total Other                                                         1,740 
                                                                            
* - The 'with or without' method is utilized to determine the income tax    
effect of all non-GAAP adjustments.                                         
                                                                            
These tables include financial measures adjusted for the impact of certain  
items; these financial measures are therefore not calculated in accordance  
with U.S. generally accepted accounting principles ("GAAP"). These Non-GAAP 
financial measures exclude items such as: share-based compensation expense; 
charges relating to restructuring initiatives; non-cash asset impairments;  
certain other non-operating gains and losses; and acquisition-related items 
such as transaction costs, non-cash amortization of acquired intangible     
assets, and incremental transaction-related compensation.                   
                                                                            
These Non-GAAP financial measures may be different from Non-GAAP financial  
measures used by other companies. Non-GAAP financial measures should not be 
considered a substitute for, or superior to, measures of financial          
performance prepared in accordance with GAAP. By excluding these items, Non-
GAAP financial measures are intended to facilitate meaningful comparisons to
historical operating results, competitors' operating results, and estimates 
made by securities analysts. Management is evaluated on key performance     
metrics including adjusted EBITDA, which is used to determine management    
incentive compensation as well as to forecast future periods. These Non-GAAP
financial measures may be useful to investors in allowing for greater       
transparency of supplemental information used by management in its financial
and operational decision-making. In addition, similar Non-GAAP financial    
measures have historically been reported to investors; the inclusion of     
comparable numbers provides consistency in financial reporting. Investors   
are encouraged to review the reconciliation of the Non-GAAP financial       
measures used in this news release to their most directly comparable GAAP   
financial measures.                                                         
                                                                            
                                                                            
                  Veeco Instruments Inc. and Subsidiaries                   
             Reconciliation of GAAP to Non-GAAP Financial Data              
                  (in thousands, except per share amounts)                  
                                (unaudited)                                 
                                                                            
                                     Non-GAAP Adjustments                   
                              -----------------------------------           
Three months ended             Share-based                                  
December 31, 2015     GAAP    Compensation  Amortization  Other    Non-GAAP 
------------------ ---------- ------------- ------------ -------- ----------
Net sales          $ 106,543                                      $ 106,543 
Gross profit          38,786           393                           39,179 
Gross margin            36.4%                                          36.8%
Research and                                                                
 development          20,639        (1,292)                          19,347 
Selling, general,                                                           
 and                                                                        
 administrative                                                             
 and Other            21,134        (2,277)                 (188)    18,669 
Net income (loss)     (9,788)        3,962         5,802     598        574 
                                                                            
Income (loss) per                                                           
 common share:                                                              
  Basic            $   (0.25)                                     $    0.01 
  Diluted              (0.25)                                          0.01 
Weighted average                                                            
 number of shares:                                                          
  Basic               39,794                                         40,644 
  Diluted             39,794                                         40,731 
                                                                            
                  Veeco Instruments Inc. and Subsidiaries                   
                         Other Non-GAAP Adjustments                         
                               (in thousands)                               
                                (unaudited)                                 
Three months ended                                                          
December 31, 2015                                                           
------------------                                                          
  Restructuring                                                       1,170 
  Acquisition                                                               
   related                                                              188 
  Non-GAAP tax                                                              
   adjustment *                                                        (760)
                                                                  ----------
    Total Other                                                         598 
                                                                            
* - The 'with or without' method is utilized to determine the income tax    
effect of all non-GAAP adjustments.                                         
                                                                            
These tables include financial measures adjusted for the impact of certain  
items; these financial measures are therefore not calculated in accordance  
with U.S. generally accepted accounting principles ("GAAP"). These Non-GAAP 
financial measures exclude items such as: share-based compensation expense; 
charges relating to restructuring initiatives; non-cash asset impairments;  
certain other non-operating gains and losses; and acquisition-related items 
such as transaction costs, non-cash amortization of acquired intangible     
assets, and incremental transaction-related compensation.                   
                                                                            
These Non-GAAP financial measures may be different from Non-GAAP financial  
measures used by other companies. Non-GAAP financial measures should not be 
considered a substitute for, or superior to, measures of financial          
performance prepared in accordance with GAAP. By excluding these items, Non-
GAAP financial measures are intended to facilitate meaningful comparisons to
historical operating results, competitors' operating results, and estimates 
made by securities analysts. Management is evaluated on key performance     
metrics including adjusted EBITDA, which is used to determine management    
incentive compensation as well as to forecast future periods. These Non-GAAP
financial measures may be useful to investors in allowing for greater       
transparency of supplemental information used by management in its financial
and operational decision-making. In addition, similar Non-GAAP financial    
measures have historically been reported to investors; the inclusion of     
comparable numbers provides consistency in financial reporting. Investors   
are encouraged to review the reconciliation of the Non-GAAP financial       
measures used in this news release to their most directly comparable GAAP   
financial measures.                                                         
                                                                            
                                                                            
                  Veeco Instruments Inc. and Subsidiaries                   
        Reconciliation of GAAP Net Income (loss) to Adjusted EBITDA         
                               (in thousands)                               
                                (unaudited)                                 
                                                                            
                                                      Three months ended    
                                                         December 31,       
                                                   -------------------------
                                                       2016         2015    
                                                   ------------ ------------
GAAP Net income (loss)                             $    (4,998) $    (9,788)
Share-based compensation                                 3,579        3,962 
Amortization                                             3,434        5,802 
Asset impairment                                          (142)           - 
Restructuring                                            1,646        1,170 
Acquisition related                                         44          188 
Accelerated depreciation                                   362            - 
ALD liquidation                                           (429)           - 
Interest income                                           (245)        (145)
Depreciation                                             2,845        3,282 
Income tax expense (benefit)                                90          (26)
                                                   -------------------------
Adjusted EBITDA                                    $     6,186  $     4,445 
                                                   =========================
                                                                            
This table includes financial measures adjusted for the impact of certain   
items; these financial measures are therefore not calculated in accordance  
with U.S. generally accepted accounting principles ("GAAP"). These Non-GAAP 
financial measures exclude items such as: share-based compensation expense; 
charges relating to restructuring initiatives; non-cash asset impairments;  
certain other non-operating gains and losses; and acquisition-related items 
such as transaction costs, non-cash amortization of acquired intangible     
assets, and incremental transaction-related compensation.                   
                                                                            
These Non-GAAP financial measures may be different from Non-GAAP financial  
measures used by other companies. Non-GAAP financial measures should not be 
considered a substitute for, or superior to, measures of financial          
performance prepared in accordance with GAAP. By excluding these items, Non-
GAAP financial measures are intended to facilitate meaningful comparisons to
historical operating results, competitors' operating results, and estimates 
made by securities analysts. Management is evaluated on key performance     
metrics including adjusted EBITDA, which is used to determine management    
incentive compensation as well as to forecast future periods. These Non-GAAP
financial measures may be useful to investors in allowing for greater       
transparency of supplemental information used by management in its financial
and operational decision-making. In addition, similar Non-GAAP financial    
measures have historically been reported to investors; the inclusion of     
comparable numbers provides consistency in financial reporting. Investors   
are encouraged to review the reconciliation of the Non-GAAP financial       
measures used in this news release to their most directly comparable GAAP   
financial measures.                                                         
                                                                            
                                                                            
                  Veeco Instruments Inc. and Subsidiaries                   
             Reconciliation of GAAP to Non-GAAP Financial Data              
                  (in thousands, except per share amounts)                  
                                (unaudited)                                 
                                                                            
                                     Non-GAAP Adjustments                   
                              -----------------------------------           
For the year ended             Share-based                                  
December 31, 2016     GAAP    Compensation  Amortization  Other    Non-GAAP 
------------------ ---------- ------------- ------------ -------- ----------
Net sales          $ 332,451                                      $ 332,451 
Gross profit         132,858         1,956                   716    135,530 
Gross margin            40.0%                                          40.8%
Research and                                                                
 development          81,016        (3,324)                          77,692 
Selling, general,                                                           
 and                                                                        
 administrative                                                             
 and Other            77,866       (10,433)               (1,537)    65,896 
Net income (loss)   (122,210)       15,713        19,219  75,954    (11,324)
                                                                            
Income (loss) per                                                           
 common share:                                                              
  Basic            $   (3.11)                                     $   (0.29)
  Diluted              (3.11)                                         (0.29)
Weighted average                                                            
 number of shares:                                                          
  Basic               39,340                                         39,340 
  Diluted             39,340                                         39,340 
                                                                            
                  Veeco Instruments Inc. and Subsidiaries                   
                         Other Non-GAAP Adjustments                         
                               (in thousands)                               
                                (unaudited)                                 
For the year ended                                                          
December 31, 2016                                                           
------------------                                                          
  Asset impairment                                                   69,520 
  Restructuring                                                       5,640 
  Acquisition                                                               
   related                                                              232 
  Accelerated                                                               
   depreciation                                                         716 
  Pension                                                                   
   termination                                                        1,305 
  ALD liquidation                                                      (429)
  Non-GAAP tax                                                              
   adjustment *                                                      (1,030)
                                                                  ----------
    Total Other                                                      75,954 
                                                                            
* - The 'with or without' method is utilized to determine the income tax    
effect of all non-GAAP adjustments.                                         
                                                                            
These tables include financial measures adjusted for the impact of certain  
items; these financial measures are therefore not calculated in accordance  
with U.S. generally accepted accounting principles ("GAAP"). These Non-GAAP 
financial measures exclude items such as: share-based compensation expense; 
charges relating to restructuring initiatives; non-cash asset impairments;  
certain other non-operating gains and losses; and acquisition-related items 
such as transaction costs, non-cash amortization of acquired intangible     
assets, and incremental transaction-related compensation.                   
                                                                            
These Non-GAAP financial measures may be different from Non-GAAP financial  
measures used by other companies. Non-GAAP financial measures should not be 
considered a substitute for, or superior to, measures of financial          
performance prepared in accordance with GAAP. By excluding these items, Non-
GAAP financial measures are intended to facilitate meaningful comparisons to
historical operating results, competitors' operating results, and estimates 
made by securities analysts. Management is evaluated on key performance     
metrics including adjusted EBITDA, which is used to determine management    
incentive compensation as well as to forecast future periods. These Non-GAAP
financial measures may be useful to investors in allowing for greater       
transparency of supplemental information used by management in its financial
and operational decision-making. In addition, similar Non-GAAP financial    
measures have historically been reported to investors; the inclusion of     
comparable numbers provides consistency in financial reporting. Investors   
are encouraged to review the reconciliation of the Non-GAAP financial       
measures used in this news release to their most directly comparable GAAP   
financial measures.                                                         
                                                                            
                                                                            
                                                                            
                  Veeco Instruments Inc. and Subsidiaries                   
             Reconciliation of GAAP to Non-GAAP Financial Data              
                  (in thousands, except per share amounts)                  
                                (unaudited)                                 
                                                                            
                                     Non-GAAP Adjustments                   
                              -----------------------------------           
For the year ended             Share-based                                  
December 31, 2015     GAAP    Compensation  Amortization  Other    Non-GAAP 
------------------ ---------- ------------- ------------ -------- ----------
Net sales          $ 477,038                                      $ 477,038 
Gross profit         177,241         2,495                 1,311    181,047 
Gross margin            37.2%                                          38.0%
Research and                                                                
 development          78,543        (4,031)                          74,512 
Selling, general,                                                           
 and                                                                        
 administrative                                                             
 and Other            89,491       (11,474)                 (958)    77,059 
Net income (loss)    (31,978)       18,000        27,634   8,408     22,064 
                                                                            
Income (loss) per                                                           
 common share:                                                              
  Basic            $   (0.80)                                     $    0.54 
  Diluted              (0.80)                                          0.54 
Weighted average                                                            
 number of shares:                                                          
  Basic               39,742                                         40,759 
  Diluted             39,742                                         40,905 
                                                                            
                  Veeco Instruments Inc. and Subsidiaries                   
                         Other Non-GAAP Adjustments                         
                               (in thousands)                               
                                (unaudited)                                 
For the year ended                                                          
December 31, 2015                                                           
------------------                                                          
  Restructuring                                                       4,679 
  Acquisition                                                               
   related - PSP                                                            
   inventory fair                                                           
   value step-up                                                      1,311 
  Acquisition                                                               
   related                                                              563 
  Asset Impairment                                                      126 
  One-time legal                                                            
   settlement                                                           395 
  Non-GAAP tax                                                              
   adjustment *                                                       1,334 
                                                                  ----------
    Total Other                                                       8,408 
                                                                            
* - The 'with or without' method is utilized to determine the income tax    
effect of all non-GAAP adjustments.                                         
                                                                            
These tables include financial measures adjusted for the impact of certain  
items; these financial measures are therefore not calculated in accordance  
with U.S. generally accepted accounting principles ("GAAP"). These Non-GAAP 
financial measures exclude items such as: share-based compensation expense; 
charges relating to restructuring initiatives; non-cash asset impairments;  
certain other non-operating gains and losses; and acquisition-related items 
such as transaction costs, non-cash amortization of acquired intangible     
assets, and incremental transaction-related compensation.                   
                                                                            
These Non-GAAP financial measures may be different from Non-GAAP financial  
measures used by other companies. Non-GAAP financial measures should not be 
considered a substitute for, or superior to, measures of financial          
performance prepared in accordance with GAAP. By excluding these items, Non-
GAAP financial measures are intended to facilitate meaningful comparisons to
historical operating results, competitors' operating results, and estimates 
made by securities analysts. Management is evaluated on key performance     
metrics including adjusted EBITDA, which is used to determine management    
incentive compensation as well as to forecast future periods. These Non-GAAP
financial measures may be useful to investors in allowing for greater       
transparency of supplemental information used by management in its financial
and operational decision-making. In addition, similar Non-GAAP financial    
measures have historically been reported to investors; the inclusion of     
comparable numbers provides consistency in financial reporting. Investors   
are encouraged to review the reconciliation of the Non-GAAP financial       
measures used in this news release to their most directly comparable GAAP   
financial measures.                                                         
                                                                            
                                                                            
                                                                            
                  Veeco Instruments Inc. and Subsidiaries                   
        Reconciliation of GAAP Net Income (loss) to Adjusted EBITDA         
                               (in thousands)                               
                                (unaudited)                                 
                                                                            
                                                      For the year ended    
                                                         December 31,       
                                                   -------------------------
                                                       2016         2015    
                                                   ------------ ------------
GAAP Net income (loss)                             $  (122,210) $   (31,978)
Share-based compensation                                15,713       18,000 
Amortization                                            19,219       27,634 
Asset impairment                                        69,520          126 
Restructuring                                            5,640        4,679 
Acquisition related - PSP inventory fair value                              
 step-up                                                     -        1,311 
Acquisition related                                        232          563 
One-time legal settlement                                    -          395 
Accelerated depreciation                                   716            - 
ALD liquidation                                           (429)           - 
Pension termination                                      1,305            - 
Interest income                                           (958)        (586)
Depreciation                                            12,714       12,216 
Income tax expense (benefit)                             2,766        9,332 
                                                   -------------------------
Adjusted EBITDA                                    $     4,228  $    41,692 
                                                   =========================
                                                                            
This table includes financial measures adjusted for the impact of certain   
items; these financial measures are therefore not calculated in accordance  
with U.S. generally accepted accounting principles ("GAAP"). These Non-GAAP 
financial measures exclude items such as: share-based compensation expense; 
charges relating to restructuring initiatives; non-cash asset impairments;  
certain other non-operating gains and losses; and acquisition-related items 
such as transaction costs, non-cash amortization of acquired intangible     
assets, and incremental transaction-related compensation.                   
                                                                            
These Non-GAAP financial measures may be different from Non-GAAP financial  
measures used by other companies. Non-GAAP financial measures should not be 
considered a substitute for, or superior to, measures of financial          
performance prepared in accordance with GAAP. By excluding these items, Non-
GAAP financial measures are intended to facilitate meaningful comparisons to
historical operating results, competitors' operating results, and estimates 
made by securities analysts. Management is evaluated on key performance     
metrics including adjusted EBITDA, which is used to determine management    
incentive compensation as well as to forecast future periods. These Non-GAAP
financial measures may be useful to investors in allowing for greater       
transparency of supplemental information used by management in its financial
and operational decision-making. In addition, similar Non-GAAP financial    
measures have historically been reported to investors; the inclusion of     
comparable numbers provides consistency in financial reporting. Investors   
are encouraged to review the reconciliation of the Non-GAAP financial       
measures used in this news release to their most directly comparable GAAP   
financial measures.                                                         
                                                                            
                                                                            
                                                                            
                  Veeco Instruments Inc. and Subsidiaries                   
             Reconciliation of GAAP to Non-GAAP Financial Data              
                  (in millions, except per share amounts)                   
                                (unaudited)                                 
                                                                            
                                      Non-GAAP Adjustments                  
                                   -------------------------                
Guidance for the                     Share-                                 
 three months                        based                                  
 ended March 31,                   Compensa- Amortiza-                      
 2017                  GAAP          tion      tion    Other    Non-GAAP    
---------------- ----------------- --------- --------- ----- ---------------
Net sales        $   85  - $  100                            $  85  - $ 100 
                                                                            
Gross profit         32  -     39          1         -     0    33  -    40 
  Gross margin       37% -     39%                              38% -    40%
                                                                            
Net income                                                                  
 (loss)          $  (11) - $   (5)         4         3     4 $   0  - $   6 
                                                                            
Income (loss)                                                               
 per diluted                                                                
 common share    $(0.28) - $(0.12)                           $0.00  - $0.16 
  Weighted                                                                  
   average                                                                  
   number of                                                                
   shares            39        39                               40       40 
                                                                            
                  Veeco Instruments Inc. and Subsidiaries                   
        Reconciliation of GAAP Net Income (loss) to Adjusted EBITDA         
                               (in millions)                                
                                (unaudited)                                 
                                                                            
Guidance for the                                                            
 three months                                                               
 ended March 31,                                                            
 2017                                                                       
----------------                                                            
GAAP Net income                                                             
 (loss)                                                      $ (11) - $  (5)
Share-based                                                                 
 compensation                                                    4  -     4 
Amortization                                                     3  -     3 
Restructuring                                                    2  -     2 
Acquisition                                                                 
 related expense                                                 2  -     2 
Interest                                                                    
 (income)                                                                   
 expense                                                         4  -     4 
Depreciation                                                     3  -     3 
Income tax                                                                  
 expense                                                                    
 (benefit) *                                                    (2) -    (2)
                                                             ---------------
Adjusted EBITDA                                              $   5  - $  11 
                                                             ===============
                                                                            
Note: Amounts may not calculate precisely due to rounding.                  
                                                                            
* - The 'with or without' method is utilized to determine the income tax    
effect of all non-GAAP adjustments.                                         
                                                                            
These tables include financial measures adjusted for the impact of certain  
items; these financial measures are therefore not calculated in accordance  
with U.S. generally accepted accounting principles ("GAAP"). These Non-GAAP 
financial measures exclude items such as: share-based compensation expense; 
charges relating to restructuring initiatives; non-cash asset impairments;  
certain other non-operating gains and losses; and acquisition-related items 
such as transaction costs, non-cash amortization of acquired intangible     
assets, and incremental transaction-related compensation.                   
                                                                            
These Non-GAAP financial measures may be different from Non-GAAP financial  
measures used by other companies. Non-GAAP financial measures should not be 
considered a substitute for, or superior to, measures of financial          
performance prepared in accordance with GAAP. By excluding these items, Non-
GAAP financial measures are intended to facilitate meaningful comparisons to
historical operating results, competitors' operating results, and estimates 
made by securities analysts. Management is evaluated on key performance     
metrics including adjusted EBITDA, which is used to determine management    
incentive compensation as well as to forecast future periods. These Non-GAAP
financial measures may be useful to investors in allowing for greater       
transparency of supplemental information used by management in its financial
and operational decision-making. In addition, similar Non-GAAP financial    
measures have historically been reported to investors; the inclusion of     
comparable numbers provides consistency in financial reporting. Investors   
are encouraged to review the reconciliation of the Non-GAAP financial       
measures used in this news release to their most directly comparable GAAP   
financial measures.                                                         
                                                                            
                                                                            
   Veeco Contacts:Investors: Shanye Hudson 516-677-0200 x1272 [email protected]:Jeffrey Pina 516-677-0200 x1222 [email protected]

Source: Veeco Instruments Inc.

Categories

Press Releases

Next Articles